Last month was one to forget for the generic-drug industry, which was confronted head-on by a sweeping lawsuit from dozens of states alleging conspiracy to fix drug prices. Shares of nearly every company with ties to generic-drug manufacturing or distribution sank on news of the legal risks.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,